Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Burkitt Lymphoma × Transplantation Conditioning × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myelodysplastic Syndromes 2 Stomatitis 1 Myeloproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Graft vs Host Disease 1 Burkitt Lymphoma 1

Interventions

Cyclophosphamide 100 Rituximab 58 Etoposide 52 Cytarabine 46 Methotrexate 45 Peripheral Blood Stem Cell Transplantation 40 Vincristine 39 Filgrastim 39 fludarabine phosphate 36 Radiotherapy 35 Whole-Body Irradiation 31 Mycophenolic Acid 31 Doxorubicin 31 Tacrolimus 29 Busulfan 29 Prednisone 28 Dexamethasone 25 Antilymphocyte Serum 24 Methylprednisolone 23 Melphalan 22 Cyclosporine 22 merphos 17 Leucovorin 16 blinatumomab 15 Granulocyte Colony-Stimulating Factor 15 Carmustine 15 fludarabine 14 CT-P10 14 Calcium Dobesilate 13 Ifosfamide 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01516593 2022-08-04

CARMEN

IRCCS San Raffaele

Phase 2 Completed

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡